Intra-Cellular Therapies Inc (NASDAQ:ITCI)
| 53.78 Delayed Data As of 3:59pm ET |  +1.15 / +2.19%Today’s Change | 42.01 Today|||52-Week Range 67.05 | +1.63% Year-to-Date |
Institutional investors purchased a net $1.0 million shares of ITCI during the quarter ended June 2019, and now own 88.56% of the total float, a percentage that is typical for companies in the Biotechnology industry.
| Mutual fund holders | 54.18% |
| Other institutional | 34.39% |
| Individual stakeholders | 14.02% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 6/30/2023 | LORD, ABBETT & CO. LLC Bought 588.8 Thousand shares of Intra-Cellular Therapies ... |
| 6/30/2023 | HOLOCENE ADVISORS, LP Bought 579.5 Thousand shares of Intra-Cellular Therapies ... |
| 6/30/2023 | MACQUARIE INVESTMENT MANAGEMENT ... Bought 568.4 Thousand shares of Intra-Cellular Therapies ... |
Top 10 Owners of Intra-Cellular Therapies Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Fidelity Management & Research Co... | 11.62% | 11,169,305 | 620,119,814 | -758,252 | -6.36% |
| The Vanguard Group, Inc. | 8.57% | 8,234,656 | 457,188,101 | +36,321 | +0.44% |
| BlackRock Fund Advisors | 6.72% | 6,457,100 | 358,498,192 | +287,266 | +4.66% |
| Wasatch Advisors, Inc. | 3.63% | 3,485,019 | 193,488,255 | -994,557 | -22.20% |
| Bellevue Asset Management AG | 3.33% | 3,201,800 | 177,763,936 | -66,200 | -2.03% |
| SSgA Funds Management, Inc. | 2.19% | 2,105,705 | 116,908,742 | +79,477 | +3.92% |
| AllianceBernstein LP | 2.12% | 2,040,802 | 113,305,327 | +37,752 | +1.88% |
| Invesco Advisers, Inc. | 1.94% | 1,866,424 | 103,623,860 | +121,953 | +6.99% |
| Geode Capital Management LLC | 1.91% | 1,836,757 | 101,976,749 | +87,739 | +5.02% |
| Franklin Advisers, Inc. | 1.87% | 1,797,120 | 99,776,102 | +15,646 | +0.88% |
Top 10 Mutual Funds Holding Intra-Cellular Therapies Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| BB Biotech AG | 3.28% | 3,150,000 | 174,888,000 | -65,000 | -2.02% |
| Fidelity Growth Company Fund | 3.05% | 2,933,339 | 162,858,981 | 0 | 0.00% |
| Vanguard Total Stock Market ETF | 2.78% | 2,670,176 | 148,248,172 | -270 | -0.01% |
| Vanguard Small Cap Index Fund | 2.34% | 2,247,969 | 124,807,239 | +8,588 | +0.38% |
| iShares Russell 2000 ETF | 2.18% | 2,099,119 | 116,543,087 | -2,960 | -0.14% |
| Vanguard Small Cap Growth Index F... | 1.34% | 1,284,838 | 71,334,206 | +4,660 | +0.36% |
| Vanguard Extended Market Index Fu... | 1.27% | 1,222,569 | 67,877,031 | +1,176 | +0.10% |
| Government Pension Fund - Global ... | 1.27% | 1,220,439 | 67,758,773 | +406,054 | +49.86% |
| Fidelity Growth Company K6 Fund | 1.02% | 983,651 | 54,612,304 | 0 | 0.00% |
| FTIF SICAV - Biotechnology Discov... | 0.99% | 948,458 | 52,658,388 | 0 | 0.00% |